|
|
Meta-analysis of Butylphthalide in treatment of delayed encephalopathy after acute carbon monoxide poisoning |
WANG Qiang GUO Yang LIU Yao ZHAO Yingqian▲ |
Acupuncture Combined with Innovative Research Center, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China |
|
|
Abstract Objective To compare the efficacy and safety of Butylphthalide in treatment of delayed encephalopathy after acute carbon monoxide poisoning. Methods Up to January 2018, PubMed, EMBase, the Cochrane Library, Wed of Science CBM, CNKI, VIP, Wanfang Data were searched to collect randomized controlled trials (RCTs) about Butylphthalide in treatment of delayed encephalopathy after acute carbon monoxide poisoning. The RCTs selected, study quality assessed, and data extracted were carried by two researchers independently. According to the evaluation system of Cochrane Handbook, the included RCTs were analyzed by using RevMan 5.3 software. Results Eleven studies were included and contained total 678 patients. Control group: treated with Butylphthalide; test group: routine/other treatment. The total effective rate of test group were higher than that of control group (OR = 5.62, 95%CI: 3.31-9.56, P < 0.01). The MMSE scale scores of test group were better than control group (SMD = 5.18, 95%CI: 3.72-6.64, Z = 6.96, P < 0.01). The BI scale scores of test group were better than control group (SMD = 16.39, 95%CI: 11.78-21.01, P < 0.01). Conclusion Butylphthalide is safe and effective to treat delayed encephalopathy after carbon monoxide poisoning.
|
|
|
|
|
[1] Zhang J,Wu H,Zhao Y,et al. Therapeutic effects of hydrogen sulfidein treating delayed encephalopathy after Acute carbon monoxide poisoning [J]. Am J Ther,2016,23(6):e1709-e1714.
[2] Mi TR,Cayia A,Olgun H. Delayed encephalopathy after acute carbon monoxide poisoning [J]. Dicle Med J,2014, 41(4):217-218.
[3] Tormoehlen LM. Toxic leukoencephalopathies [J]. Neurol Clin,2011,29(3):591-605.
[4] 吕信鹏,邓颖.一氧化碳中毒迟发性脑病的相关研究进展[J].医学综述,2017,23(1):100-103.
[5] 史玉泉.实用神经病学[M].2版.上海:上海科学技术出版社,1992.
[6] 丁彦博.丁苯酞治疗一氧化碳中毒所致迟发性脑病的效果研究[J].当代医药论丛,2017,15(2):74-75.
[7] 于园园.丁苯酞治疗一氧化碳中毒迟发性脑病疗效观察[C]//中华医学会急诊医学分会第17次全国急诊医学学术年会论文集,2014.
[8] 史艳.丁苯酞治疗一氧化碳中毒后迟发性脑病的临床观察[J].临床荟萃,2009,24(7):618-618.
[9] 孙国兵,曾铮,余丹芳,等.高压氧联合丁苯酞治疗一氧化碳中毒迟发性脑病疗效分析[J].卒中与神经疾病,2016, 23(2):119-121.
[10] 张拥军,郭静霞,侯云生,等.丁苯酞治疗一氧化碳中毒迟发性脑病30例[J].临床荟萃,2009,24(2):154-155.
[11] 李秀娟,周景芬.丁苯酞联合高压氧对一氧化碳中毒迟发性脑病患者神经功能的影响[J].中国老年学杂志,2017, 37(23):5926-5928.
[12] 李立新,梁永胜,程桂林,等.丁苯酞氯化钠注射液联合高压氧治疗一氧化碳中毒迟发性脑病30例临床观察[J].中国现代药物应用,2016,10(9):118-119.
[13] 田书娟,鲍军强,解雄伟,等.丁苯酞氯化钠注射液对一氧化碳中毒迟发性脑病患者认知功能的影响[J].中国临床医生杂志,2016,44(12):52-54.
[14] 葛建新,文喆卿.丁苯酞注射液治疗一氧化碳中毒迟发性脑病疗效观察[J].临床医药实践,2013,22(12):897-898.
[15] 赵书鹤,李伟荣.丁苯酞软胶囊治疗一氧化碳中毒迟发性脑病的临床观察[J].中国神经免疫学和神经病学杂志,2017,24(5):349-352.
[16] 陈士利,卫青祥,王志海,等.丁苯酞治疗急性一氧化碳中毒迟发性脑病59例[J].中国药业,2009,18(13):70-71.
[17] Omaye ST. Metabolic modulation of carbon monoxide toxicity [J]. Toxicology,2002,180(2):139-150.
[18] Hou X,Ma L,Wu L,et al. Diffusion tensor imaging for predicting the clin-ical outcome of delayed encephalopathy of acute carbon monoxide poisoning [J]. Eur Neurol,2013, 69(5):275-280.
[19] 南登崑.实用康复医学[M].2版.北京:人民卫生出版社,2009:43-44.
[20] 包玉双,桑川,王超.急性CO中毒迟发性脑病相关因素分析[J].黑龙江医药科学,1999,22(1):36-37.
[21] Chan MY,Au TTS,Leung KS,et al. Acute carbon monoxide poisoning in a regional hospital in Hong Kong:historical cohort study [J]. Hong Kong Med J,2016,22(1):46-55.
[22] 熊杰,冯亦璞.丁基苯酞对局灶性脑缺血过程中线粒体损伤的保护作用[J].药学学报,2000,35(6):408-412.
[23] 胡盾,张丽英,冯亦璞.丁基苯酞对局部脑缺血大鼠记忆障碍的影响[J].中国药理与毒理杂志,1997,11(1):14-16.
[24] 陈瑞莲,陈新东,黄彦真.丁苯酞序贯治疗对血管性痴呆认知功能改善的临床观察[J].中国医药科学,2018,8(7):90-92.
[25] 林建峰,冯亦璞.丁基苯酞对局部脑缺血大鼠神经元迟发性损伤及细胞内钙的影响[J].药学学报,1996,31(3):166-170. |
|
|
|